The DOI matches its Crossref record; 442 of the 442 references it cites were found in a registry or an index.
Broad targeting of resistance to apoptosis in cancer
Open accessAbstract
Apoptosis or programmed cell death is natural way of removing aged cells from the body. Most of the anti-cancer therapies trigger apoptosis induction and related cell death networks to eliminate malignant cells. However, in cancer, de-regulated apoptotic signaling, particularly the activation of an anti-apoptotic systems, allows cancer cells to escape this program leading to uncontrolled proliferation resulting in tumor survival, therapeutic resistance and recurrence of cancer. This resistance is a complicated phenomenon that emanates from the interactions of various molecules and signaling pathways. In this comprehensive review we discuss the various factors contributing to apoptosis resistance in cancers. The key resistance targets that are discussed include (1) Bcl-2 and Mcl-1 proteins; (2) autophagy processes; (3) necrosis and necroptosis; (4) heat shock protein signaling; (5) the proteasome pathway; (6) epigenetic mechanisms; and (7) aberrant nuclear export signaling. The shortcomings of current therapeutic modalities are highlighted and a broad spectrum strategy using approaches including (a) gossypol; (b) epigallocatechin-3-gallate; (c) UMI-77 (d) triptolide and (e) selinexor that can be used to overcome cell death resistance is presented. This review provides a roadmap for the design of successful anti-cancer strategies that overcome resistance to apoptosis for better therapeutic outcome in patients with cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Huang, Q. B., Wu, Y.-T., Tan, H.-L., Ong, C.-N., & Shen, H.-M. (2008) · Cell Death and Differentiation · doi:10.1038/cdd.2008.151 · Cited by 123
RetractedPark, B., Sung, B., Yadav, V. R., Chaturvedi, M. M., & Aggarwal, B. B. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.07.062 · Cited by 26
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Repertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Mutations of the BRAF gene in human cancer
Davies, H., Bignell, G. R., Cox, C., Stephens, P., Edkins, S., Clegg, S., Teague, J., Woffendin, H., Garnett, M. J., Bottomley, W., et al. (2002) · Nature · doi:10.1038/nature00766 · Cited by 10,674
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
The Bcl2 family: regulators of the cellular life-or-death switch
Cory, S., & Adams, J. M. (2002) · Nature Reviews Cancer · doi:10.1038/nrc883 · Cited by 4,032
Missing Pieces in the NF-κB Puzzle
Ghosh, S., & Karin, M. (2002) · Cell · doi:10.1016/s0092-8674(02)00703-1 · Cited by 3,638 · cited 1×
“, radiation), chemical (cancer chemotherapeutic agents), viral and biological (cytokines, growth factors) agents induce phosphorylation, ubiquitination and subsequent degradation of I B by the proteasome, freeing up NF- B to translocate to the nucleus and modulate genes involved in proliferation, invasion and tumor su…”
Self-eating and self-killing: crosstalk between autophagy and apoptosis
Maiuri, M. C., Zalckvar, E., Kimchi, A., & Kroemer, G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2239 · Cited by 3,577
Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy
Czabotar, P. E., Lessene, G., Strasser, A., & Adams, J. M. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3722 · Cited by 3,219
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Souers, A. J., Leverson, J. D., Boghaert, E. R., Ackler, S. L., Catron, N. D., Chen, J., Dayton, B. D., Ding, H., Enschede, S. H., Fairbrother, W. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3048 · Cited by 3,058
Health effects of quercetin: From antioxidant to nutraceutical
Boots, A. W., Haenen, G. R. M. M., & Bast, A. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.03.008 · Cited by 2,121
Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4
Scherz‐Shouval, R., Shvets, E., Fass, E., Shorer, H., Gil, L., & Elazar, Z. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601623 · Cited by 2,101 · cited 2×
“[70] Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, Elazar Z.”
BackgroundAutophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis
Degenhardt, K., Mathew, R., Beaudoin, B., Bray, K., Anderson, D., Chen, G., Mukherjee, C., Shi, Y., Gélinas, C., Fan, Y., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.06.001 · Cited by 2,011
X-linked IAP is a direct inhibitor of cell-death proteases
Deveraux, Q. L., Takahashi, R., Salvesen, G. S., & Reed, J. C. (1997) · Nature · doi:10.1038/40901 · Cited by 1,955
Chen, L., Willis, S. N., Wei, A., Smith, B. J., Fletcher, J. I., Hinds, M. G., Colman, P. M., Day, C. L., Adams, J. M., & Huang, D. C. S. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.030 · Cited by 1,816
Mathew, R., Karantza-Wadsworth, V., & White, E. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2254 · Cited by 1,798
Autophagy Suppresses Tumorigenesis through Elimination of p62
Mathew, R., Karp, C. M., Beaudoin, B., Vuong, N., Chen, G., Chen, H.-Y., Bray, K., Reddy, A., Bhanot, G., Gelinas, C., et al. (2009) · Cell · doi:10.1016/j.cell.2009.03.048 · Cited by 1,719
The role of autophagy in cancer development and response to therapy
Kondo, Y., Kanzawa, T., Sawaya, R., & Kondo, S. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1692 · Cited by 1,654
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Deveraux, Q. L. (1998) · The EMBO Journal · doi:10.1093/emboj/17.8.2215 · Cited by 1,388
Melanoma biology and new targeted therapy
Gray-Schopfer, V., Wellbrock, C., & Marais, R. (2007) · Nature · doi:10.1038/nature05661 · Cited by 1,371
Regulation of an ATG7 - beclin 1 Program of Autophagic Cell Death by Caspase-8
Yu, L., Alva, A., Su, H., Dutt, P., Freundt, E., Welsh, S., Baehrecke, E. H., & Lenardo, M. J. (2004) · Science · doi:10.1126/science.1096645 · Cited by 1,220
CRM1 is responsible for intracellular transport mediated by the nuclear export signal
Fukuda, M., Asano, S., Nakamura, T., Adachi, M., Yoshida, M., Yanagida, M., & Nishida, E. (1997) · Nature · doi:10.1038/36894 · Cited by 1,211
Proteolysis: from the lysosome to ubiquitin and the proteasome
Ciechanover, A. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1552 · Cited by 1,133
Kudo, N., Matsumori, N., Taoka, H., Fujiwara, D., Schreiner, E. P., Wolff, B., Yoshida, M., & Horinouchi, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9112 · Cited by 1,029
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938
Autophagy suppresses tumor progression by limiting chromosomal instability
Mathew, R., Kongara, S., Beaudoin, B., Karp, C. M., Bray, K., Degenhardt, K., Chen, G., Jin, S., & White, E. (2007) · Genes & Development · doi:10.1101/gad.1545107 · Cited by 938
The gene encoding the splicing factor SF2/ASF is a proto-oncogene
Karni, R., de Stanchina, E., Lowe, S. W., Sinha, R., Mu, D., & Krainer, A. R. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1209 · Cited by 934
Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
Volkova, M., & Russell, R. (2012) · Current Cardiology Reviews · doi:10.2174/157340311799960645 · Cited by 872
Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death.
Korsmeyer, S. J., Shutter, J. R., Novack, D. V., Merry, D. E., & Oltvai, Z. N. (1993) · PubMed · Cited by 865
Basu, A., Bodycombe, N. E., Cheah, J. H., Price, E. V., Liu, K., Schaefer, G. I., Ebright, R. Y., Stewart, M. L., Ito, D., Wang, S., et al. (2013) · Cell · doi:10.1016/j.cell.2013.08.003 · Cited by 833
Superoxide is the major reactive oxygen species regulating autophagy
Chen, Y., Azad, M. B., & Gibson, S. B. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2009.49 · Cited by 796
β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis
Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.11.026 · Cited by 757
Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
p53 status determines the role of autophagy in pancreatic tumour development
Rosenfeldt, M. T., O’Prey, J., Morton, J. P., Nixon, C., MacKay, G., Mrowinska, A., Au, A., Rai, T. S., Zheng, L., Ridgway, R., et al. (2013) · Nature · doi:10.1038/nature12865 · Cited by 713
Chow, H.-H. S., Cai, Y., Hakim, I. A., Crowell, J. A., Shahi, F., Brooks, C. A., Dorr, R. T., Hara, Y., & Alberts, D. S. (2003) · PubMed · Cited by 706
Forman, H. J., Davies, K. J. A., & Ursini, F. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.05.045 · Cited by 703
The flavonoid quercetin in disease prevention and therapy: Facts and fancies
Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., & Russo, G. L. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.08.010 · Cited by 698
Self-citationPotential anticancer activity of turmeric (Curcuma longa)
Kuttan, R., Bhanumathy, P., Nirmala, K., & George, M. C. (1985) · Cancer Letters · doi:10.1016/0304-3835(85)90159-4 · Cited by 687
FAP-1: A Protein Tyrosine Phosphatase That Associates with Fas
Sato, T., Irie, S., Kitada, S., & Reed, J. C. (1995) · Science · doi:10.1126/science.7536343 · Cited by 683
Salmonella induces macrophage death by caspase‐1‐dependent necrosis
Brennan, M. A., & Cookson, B. T. (2000) · Molecular Microbiology · doi:10.1046/j.1365-2958.2000.02103.x · Cited by 674
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
Gandhi, L., Camidge, D. R., Ribeiro de Oliveira, M., Bonomi, P., Gandara, D., Khaira, D., Hann, C. L., McKeegan, E. M., Litvinovich, E., Hemken, P. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6208 · Cited by 603
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells
Messmer, B. T., Messmer, D., Allen, S. L., Kolitz, J. E., Kudalkar, P., Cesar, D., Murphy, E. J., Koduru, P., Ferrarini, M., Zupo, S., et al. (2005) · Journal of Clinical Investigation · doi:10.1172/jci200523409 · Cited by 599
Morphological and Biochemical Aspects of Apoptosis, Oncosis and Necrosis
Van Cruchten, S., & Van den Broeck, W. (2002) · Anatomia, Histologia, Embryologia · doi:10.1046/j.1439-0264.2002.00398.x · Cited by 547
Chakravarti, A., Loeffler, J. S., & Dyson, N. J. (2002) · PubMed · Cited by 542
Alt, J. R., Cleveland, J. L., Hannink, M., & Diehl, J. A. (2000) · Genes & Development · doi:10.1101/gad.854900 · Cited by 535
Walker, N. I., HARMON, B. V., Gobe, G. C., & Kerr, J. F. R. (1988) · PubMed · Cited by 527
IAP-targeted therapies for cancer
LaCasse, E. C., Mahoney, D. J., Cheung, H. H., Plenchette, S., Baird, S., & Korneluk, R. G. (2008) · Oncogene · doi:10.1038/onc.2008.302 · Cited by 524
Ester Bond-containing Tea Polyphenols Potently Inhibit Proteasome Activity in Vitro and in Vivo
Nam, S., Smith, D. M., & Dou, Q. P. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m004209200 · Cited by 504
Self-citationMolecular targeting therapy of cancer: drug resistance, apoptosis and survival signal
Tsuruo, T., Naito, M., Tomida, A., Fujita, N., Mashima, T., Sakamoto, H., & Haga, N. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01345.x · Cited by 502
Multiple Drug Resistance Mechanisms in Cancer
Baguley, B. C. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9321-2 · Cited by 478
Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib
Haas-Kogan, D. A., Prados, M. D., Tihan, T., Eberhard, D. A., Jelluma, N., Arvold, N. D., Baumber, R., Lamborn, K. R., Kapadia, A., Malec, M., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji161 · Cited by 465
Lai, A., Tran, A., Nghiemphu, P. L., Pope, W. B., Solis, O. E., Selch, M., Filka, E., Yong, W. H., Mischel, P. S., Liau, L. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2729 · Cited by 458
Srinivasula, S. M., & Ashwell, J. D. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.008 · Cited by 450
Grossman, S. A., Ye, X., Piantadosi, S., Desideri, S., Nabors, L. B., Rosenfeld, M., Fisher, J., & for the NABTT CNS Consortium (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-3106 · Cited by 448
Li, B., & Dou, Q. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.070047997 · Cited by 446
Self-citationRegulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network
Kang, B. H., Plescia, J., Dohi, T., Rosa, J., Doxsey, S. J., & Altieri, D. C. (2007) · Cell · doi:10.1016/j.cell.2007.08.028 · Cited by 443
Garcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Dynamics and interplay of nuclear architecture, genome organization, and gene expression
Schneider, R., & Grosschedl, R. (2007) · Genes & Development · doi:10.1101/gad.1604607 · Cited by 420
20S Proteasome and Its Inhibitors: Crystallographic Knowledge for Drug Development
Borissenko, L., & Groll, M. (2007) · Chemical Reviews · doi:10.1021/cr0502504 · Cited by 407
Curcumin, a component of turmeric: From farm to pharmacy
Gupta, S. C., Kismali, G., & Aggarwal, B. B. (2013) · BioFactors · doi:10.1002/biof.1079 · Cited by 396
Autophagy in Cancer: Good, Bad, or Both?
Hippert, M. M., O'Toole, P. S., & Thorburn, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1597 · Cited by 396
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
CRM1-mediated nuclear export: to the pore and beyond
Hutten, S., & Kehlenbach, R. H. (2007) · Trends in Cell Biology · doi:10.1016/j.tcb.2007.02.003 · Cited by 382
Nuclear import by karyopherin-βs: Recognition and inhibition
Chook, Y. M., & Süel, K. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2010.10.014 · Cited by 375
Nuclear pore complex composition: a new regulator of tissue-specific and developmental functions
Raices, M., & D'Angelo, M. A. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3461 · Cited by 374
Caspase-independent cell death in T lymphocytes
Jäättelä, M., & Tschopp, J. (2003) · Nature Immunology · doi:10.1038/ni0503-416 · Cited by 367
Dighiero, G., & Hamblin, T. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60456-0 · Cited by 366
Pancreatic cancer: understanding and overcoming chemoresistance
Wang, Z., Li, Y., Ahmad, A., Banerjee, S., Azmi, A. S., Kong, D., & Sarkar, F. H. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.188 · Cited by 364
Self-citationBcl-2:Beclin 1 complex: multiple, mechanisms regulating autophagy/apoptosis toggle switch.
Marquez, R. T., & Xu, L. (2012) · Europe PMC (PubMed Central) · Cited by 363
Acquired resistance to ABT-737 in lymphoma cells that up-regulate MCL-1 and BFL-1
Yecies, D., Carlson, N. E., Deng, J., & Letai, A. (2010) · Blood · doi:10.1182/blood-2009-07-233304 · Cited by 360
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
Vogler, M., Dinsdale, D., Dyer, M. J. S., & Cohen, G. M. (2009) · Cell Death & Differentiation · doi:10.1038/cdd.2008.137 · Cited by 357
Azad, M. B., Chen, Y., Henson, E. S., Cizeau, J., McMillan-Ward, E., Israels, S. J., & Gibson, S. B. (2008) · Autophagy · doi:10.4161/auto.5278 · Cited by 355
Deadly encounter: ubiquitin meets apoptosis
Jesenberger, V., & Jentsch, S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm731 · Cited by 355
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Joo, K. M., Kim, S. Y., Jin, X., Song, S. Y., Kong, D.-S., Lee, J.-I., Jeon, J. W., Kim, M. H., Kang, B. G., Jung, Y., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.57 · Cited by 337
An, B., Goldfarb, R. H., Siman, R., & Dou, Q. P. (1998) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400436 · Cited by 337
Self-citationHirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 333
Central Role of the Proteasome in Senescence and Survival of Human Fibroblasts
Chondrogianni, N., Stratford, F. L. L., Trougakos, I. P., Friguet, B., Rivett, A. J., & Gonos, E. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301048200 · Cited by 332
Mcl-1 is a potential therapeutic target in multiple types of cancer
Akgul, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8637-6 · Cited by 329
Geisler, S. B., Lønning, P. E., Aas, T., Johnsen, H., Fluge, Ø., Haugen, D. F., Lillehaug, J. R., Akslen, L. A., & Børresen‐Dale, A. (2001) · PubMed · Cited by 326
BCL2A1: the underdog in the BCL2 family
Vogler, M. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.158 · Cited by 325
Interdigital cell death can occur through a necrotic and caspase-independent pathway
Chautan, M., Chazal, G., Cecconi, F., Gruss, P., & Golstein, P. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80425-4 · Cited by 324
Longo, P. G., Laurenti, L., Gobessi, S., Sica, S., Leone, G., & Efremov, D. G. (2008) · Blood · doi:10.1182/blood-2007-05-089037 · Cited by 321
Regulation of survivin function by Hsp90
Fortugno, P., Beltrami, E., Plescia, J., Fontana, J., Pradhan, D., Marchisio, P. C., Sessa, W. C., & Altieri, D. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2434345100 · Cited by 318
Dimmeler, S., Breitschopf, K., Haendeler, J., & Zeiher, A. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1815 · Cited by 314
Tai, Y.-T., Landesman, Y., Acharya, C., Calle, Y., Zhong, M. Y., Cea, M., Tannenbaum, D., Cagnetta, A., Reagan, M., Munshi, A. A., et al. (2014) · Leukemia · doi:10.1038/leu.2013.115 · Cited by 308
ROS-mediated mechanisms of autophagy stimulation and their relevance in cancer therapy
Dewaele, M., Maes, H., & Agostinis, P. (2010) · Autophagy · doi:10.4161/auto.6.7.12113 · Cited by 306
Krakstad, C., & Chekenya, M. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-135 · Cited by 301
Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols
Jodoin, J., Demeule, M., & Béliveau, R. (2002) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(01)00175-6 · Cited by 300
Raf: A Strategic Target for Therapeutic Development Against Cancer
Beeram, M., Patnaik, A., & Rowinsky, E. K. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.036 · Cited by 298
STAT proteins as novel targets for cancer drug discovery
Turkson, J. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.5.409 · Cited by 295
Liang, Y.-C., Lin-shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19971001)67:1<55::aid-jcb6>3.0.co;2-v · Cited by 294
Richardson, P. G., Hideshima, T., & Anderson, K. C. (2003) · Cancer Control · doi:10.1177/107327480301000502 · Cited by 292
Structure-Based Design of Potent Small-Molecule Inhibitors of Anti-Apoptotic Bcl-2 Proteins
Wang, G., Nikolovska-Coleska, Z., Yang, C.-Y., Wang, R., Tang, G., Guo, J., Shangary, S., Qiu, S., Gao, W., Yang, D., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060460o · Cited by 292
Granzyme B: a natural born killer
Lord, S. J., Rajotte, R. V., Korbutt, G. S., & Bleackley, R. C. (2003) · Immunological Reviews · doi:10.1034/j.1600-065x.2003.00044.x · Cited by 287
Karantanos, T., Evans, C. P., Tombal, B., Thompson, T. C., Montironi, R., & Isaacs, W. B. (2015) · European Urology · doi:10.1016/j.eururo.2014.09.049 · Cited by 285
Jatoi, A., Ellison, N., Burch, P. A., Sloan, J. A., Dakhil, S. R., Novotny, P., Tan, W., Fitch, T. R., Rowland, K. M., Young, C. Y. F., et al. (2003) · Cancer · doi:10.1002/cncr.11200 · Cited by 284
Triptolide inhibits the growth and metastasis of solid tumors.
Yang, S., Chen, J., Guo, Z., Xu, X., Wang, L., Pei, X., Yang, J., Underhill, C. B., & Zhang, L. (2003) · PubMed · Cited by 283
Apoptosome Structure, Assembly, and Procaspase Activation
Yuan, S., & Akey, C. W. (2013) · Structure · doi:10.1016/j.str.2013.02.024 · Cited by 281
Robertson, L. E., Plunkett, W. K., McConnell, K., Keating, M. J., & McDonnell, T. J. (1996) · PubMed · Cited by 281
Functional Architecture of the Nuclear Pore Complex
Grossman, E., Medalia, O., & Zwerger, M. (2012) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-050511-102328 · Cited by 274
EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer
Shankar, S. (2008) · Frontiers in Bioscience · doi:10.2741/2691 · Cited by 273
Jang, J.-Y., Lee, J.-K., Jeon, Y.-K., & Kim, C.-W. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-421 · Cited by 270
Chowdhury, D., Beresford, P. J., Zhu, P., Zhang, D., Sung, J.-S., Demple, B., Perrino, F. W., & Lieberman, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.06.005 · Cited by 264
Chung, J. Y., Huang, C., Meng, X., Dong, Z., & Yang, C. S. (1999) · PubMed · Cited by 262
Wang, H., Bian, S., & Yang, C. S. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr218 · Cited by 261
Shimamura, T., Lowell, A. M., Engelman, J. A., & Shapiro, G. I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0933 · Cited by 259
Nor, J. E., Christensen, J. B., Liu, J., Peters, M., Mooney, D. J., Strieter, R. M., & Polverini, P. J. (2001) · PubMed · Cited by 257
Molecular Targets for Green Tea in Prostate Cancer Prevention
Adhami, V. M., Ahmad, N., & Mukhtar, H. (2003) · The Journal of Nutrition · doi:10.1093/jn/133.7.2417s · Cited by 253
van der Watt, P. J., Maske, C. P., Hendricks, D. T., Parker, M. I., Denny, L., Govender, D., Birrer, M. J., & Leaner, V. D. (2009) · International Journal of Cancer · doi:10.1002/ijc.24146 · Cited by 250
Newlands, E., Rustin, G., & Brampton, M. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.415 · Cited by 248
Pepper, C., Lin, T. T., Pratt, G., Hewamana, S., Brennan, P., Hiller, L., Hills, R., Ward, R., Starczynski, J., Austen, B., et al. (2008) · Blood · doi:10.1182/blood-2008-05-157131 · Cited by 248
PARP-1 is involved in autophagy induced by DNA damage
Muñoz-Gámez, J. A., Rodríguez-Vargas, J. M., Quiles-Pérez, R., Aguilar-Quesada, R., Martín-Oliva, D., de Murcia, G., de Murcia, J. M., Almendros, A., de Almodóvar, M. R., & Oliver, F. J. (2009) · Autophagy · doi:10.4161/auto.5.1.7272 · Cited by 247
THE PROTEASOME AND PROTEASOME INHIBITORS IN CANCER THERAPY
Voorhees, P. M., & Orlowski, R. Z. (2006) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.46.120604.141300 · Cited by 247
Fucoxanthin: A Marine Carotenoid Exerting Anti-Cancer Effects by Affecting Multiple Mechanisms
Kumar, S., Hosokawa, M., & Miyashita, K. (2013) · Marine Drugs · doi:10.3390/md11125130 · Cited by 246
Selective activation of p53-mediated tumour suppression in high-grade tumours
Junttila, M. R., Karnezis, A. N., Garcia, D., Madriles, F., Kortlever, R. M., Rostker, F., Brown Swigart, L., Pham, D. M., Seo, Y., Evan, G. I., et al. (2010) · Nature · doi:10.1038/nature09526 · Cited by 245
Jain, M. V., Paczulla, A. M., Klonisch, T., Dimgba, F. N., Rao, S. B., Roberg, K., Schweizer, F., Lengerke, C., Davoodpour, P., Palicharla, V. R., et al. (2013) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12001 · Cited by 240
Kang, B. H., Plescia, J., Song, H. Y., Meli, M., Colombo, G., Beebe, K., Scroggins, B., Neckers, L., & Altieri, D. C. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37613 · Cited by 240
Epigenetics as a mechanism driving polygenic clinical drug resistance
Glasspool, R. M., Teodoridis, J. M., & Brown, R. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603024 · Cited by 236
Capparelli, C., Guido, C., Whitaker-Menezes, D., Bonuccelli, G., Balliet, R., Pestell, T. G., Goldberg, A. F., Pestell, R. G., Howell, A., Sneddon, S., et al. (2012) · Cell Cycle · doi:10.4161/cc.20718 · Cited by 235
Evidence That Ser87 of BimEL Is Phosphorylated by Akt and Regulates BimEL Apoptotic Function
Qi, X.-J., Wildey, G. M., & Howe, P. H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m505546200 · Cited by 234
Liu, D., Yang, Y., Liu, Q., & Wang, J. (2011) · Medical Oncology · doi:10.1007/s12032-009-9397-3 · Cited by 233
Pepper, C., Hoy, T., & Bentley, D. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.487 · Cited by 230
Phytochemicals in Cancer Prevention and Therapy: Truth or Dare?
Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2010) · Toxins · doi:10.3390/toxins2040517 · Cited by 225
Self-citationA Short Mitochondrial Form of p19ARF Induces Autophagy and Caspase-Independent Cell Death
Reef, S., Zalckvar, E., Shifman, O., Bialik, S., Sabanay, H., Oren, M., & Kimchi, A. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.04.014 · Cited by 224
Brandes, A. A., Franceschi, E., Tosoni, A., Benevento, F., Scopece, L., Mazzocchi, V., Bacci, A., Agati, R., Calbucci, F., & Ermani, M. (2009) · Cancer · doi:10.1002/cncr.24406 · Cited by 224
Liang, Y.-C., Lin-Shiau, S.-Y., Chen, C.-F., & Lin, J.-K. (1999) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(19991001)75:1<1::aid-jcb1>3.0.co;2-n · Cited by 222
Lin, T. S., Ruppert, A. S., Johnson, A. J., Fischer, B., Heerema, N. A., Andritsos, L. A., Blum, K. A., Flynn, J. M., Jones, J. A., Hu, W., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.6944 · Cited by 222
Tagscherer, K. E., Fassl, A., Campos, B., Farhadi, M., Kraemer, A., Böck, B. C., Macher-Goeppinger, S., Radlwimmer, B., Wiestler, O. D., Herold-Mende, C., et al. (2008) · Oncogene · doi:10.1038/onc.2008.259 · Cited by 220
Autophagy inhibition enhances vorinostat‐induced apoptosis via ubiquitinated protein accumulation
Carew, J. S., Medina, E. C., Esquivel II, J. A., Mahalingam, D., Swords, R., Kelly, K., Zhang, H., Huang, P., Mita, A. C., Mita, M. M., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00832.x · Cited by 219
Autophagy and cancer – issues we need to digest
Liu, E. Y., & Ryan, K. M. (2012) · Journal of Cell Science · doi:10.1242/jcs.093708 · Cited by 219
Nrf2: control of sensitivity to carcinogens
Slocum, S. L., & Kensler, T. W. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0675-4 · Cited by 219
Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG
Berletch, J. B., Liu, C., Love, W. K., Andrews, L. G., Katiyar, S. K., & Tollefsbol, T. O. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21417 · Cited by 218
Socinski, M. A., Goldman, J., El-Hariry, I., Koczywas, M., Vukovic, V., Horn, L., Paschold, E., Salgia, R., West, H., Sequist, L. V., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3381 · Cited by 215
Adhami, V. M., Malik, A., Zaman, N., Sarfaraz, S., Siddiqui, I. A., Syed, D. N., Afaq, F., Pasha, F. S., Saleem, M., & Mukhtar, H. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2269 · Cited by 205
Tai, W.-T., Shiau, C.-W., Chen, H.-L., Liu, C.-Y., Lin, C.-S., Cheng, A.-L., Chen, P.-J., & Chen, K.-F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.18 · Cited by 202
Bottazzi, B., Walter, S., Govoni, D., Colotta, F., & Mantovani, A. (1992) · The Journal of Immunology · doi:10.4049/jimmunol.148.4.1280 · Cited by 202
Targeting Mcl-1 for the therapy of cancer
Quinn, B. A., Dash, R., Azab, B., Sarkar, S., Das, S. K., Kumar, S., Oyesanya, R. A., Dasgupta, S., Dent, P., Grant, S., et al. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.609167 · Cited by 202
Recognition of nuclear targeting signals by Karyopherin-β proteins
Xu, D., Farmer, A., & Chook, Y. M. (2010) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2010.09.008 · Cited by 197
Targeting the ubiquitin–proteasome system for cancer therapy
Shen, M., Schmitt, S., Buac, D., & Dou, Q. P. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.815728 · Cited by 197
Self-citationA novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death
Wood, T. E., Dalili, S., Simpson, C. D., Hurren, R., Mao, X., Saiz, F. S., Gronda, M., Eberhard, Y., Minden, M. D., Bilan, P. J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0569 · Cited by 195
Identification of Nuclear Export Inhibitors with Potent Anticancer Activity In vivo
Mutka, S. C., Yang, W. Q., Dong, S. D., Ward, S. L., Craig, D. A., Timmermans, P. B. M. W. M., & Murli, S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-0858 · Cited by 195
B-chronic lymphocytic leukemia: a malignancy of anti-self B cells
Caligaris-Cappio, F. (1996) · Blood · doi:10.1182/blood.v87.7.2615.bloodjournal8772615 · Cited by 195
Unique Biology of Mcl-1: Therapeutic Opportunities in Cancer
Shore, G., & Warr, M. (2008) · Current Molecular Medicine · doi:10.2174/156652408783769580 · Cited by 193
Sensitization of BCL-2–expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737
Oakes, S. R., Vaillant, F., Lim, E., Lee, L., Breslin, K., Feleppa, F., Deb, S., Ritchie, M. E., Takano, E., Ward, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1104778108 · Cited by 193
Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells
Xi, G., Hu, X., Wu, B., Jiang, H., Young, C. Y. F., Pang, Y., & Yuan, H. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.03.026 · Cited by 193
McBrayer, S. K., Cheng, J. C., Singhal, S., Krett, N. L., Rosen, S. T., & Shanmugam, M. (2012) · Blood · doi:10.1182/blood-2011-09-377846 · Cited by 192
Nuclear localization is essential for the activity of p53 protein.
Shaulsky, G., Goldfinger, N., Tosky, M. S., Levine, A. J., & Rotter, V. (1991) · PubMed · Cited by 192
Ajabnoor, G. M. A., Crook, T., & Coley, H. M. (2012) · Cell Death & Disease · doi:10.1038/cddis.2011.139 · Cited by 189
Self-citationXu, N., Zhang, J., Shen, C., Luo, Y., Xia, L., Xue, F., & Xia, Q. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.06.048 · Cited by 188
A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo
Abulwerdi, F., Liao, C., Liu, M., Azmi, A. S., Aboukameel, A., Mady, A. S. A., Gulappa, T., Cierpicki, T., Owens, S., Zhang, T., et al. (2014) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0767 · Cited by 187
Self-citationThe Pan-Bcl-2 Inhibitor (−)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma
Voss, V., Senft, C., Lang, V., Ronellenfitsch, M. W., Steinbach, J. P., Seifert, V., & Kögel, D. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-09-0562 · Cited by 186
HSP90 is a therapeutic target in JAK2-dependent myeloproliferative neoplasms in mice and humans
Marubayashi, S., Koppikar, P., Taldone, T., Abdel-Wahab, O., West, N., Bhagwat, N., Caldas-Lopes, E., Ross, K. N., Gönen, M., Gozman, A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42442 · Cited by 184
Drug resistance and the microenvironment: nature and nurture
Morin, P. J. (2003) · Drug Resistance Updates · doi:10.1016/s1368-7646(03)00059-1 · Cited by 182
Etchin, J., Sanda, T., Mansour, M. R., Kentsis, A., Montero, J., Le, B. T., Christie, A. L., McCauley, D., Rodig, S. J., Kauffman, M., et al. (2013) · British Journal of Haematology · doi:10.1111/bjh.12231 · Cited by 182
Kiviharju, T. M., Lecane, P. S., Sellers, R. G., & Peehl, D. M. (2002) · PubMed · Cited by 181
Shanafelt, T. D., Call, T. G., Zent, C. S., LaPlant, B., Bowen, D. A., Roos, M., Secreto, C. R., Ghosh, A. K., Kabat, B. F., Lee, M.-J., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.1284 · Cited by 181
Pignochino, Y., Grignani, G., Cavalloni, G., Motta, M., Tapparo, M., Bruno, S., Bottos, A., Gammaitoni, L., Migliardi, G., Camussi, G., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-118 · Cited by 180
Lv, Q., Wang, W., Xue, J., Hua, F., Mu, R., Lin, H., Yan, J., Lv, X., Chen, X., & Hu, Z.-W. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3832 · Cited by 178
Investigations on gossypol: past and present developments
Dodou, K. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.11.1419 · Cited by 177
Evolution of intracellular compartmentalization
Diekmann, Y., & Pereira-Leal, J. B. (2013) · Biochemical Journal · doi:10.1042/bj20120957 · Cited by 174
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.11.004 · Cited by 173
Shanafelt, T. D., Call, T. G., Zent, C. S., Leis, J. F., LaPlant, B., Bowen, D. A., Roos, M., Laumann, K., Ghosh, A. K., Lesnick, C., et al. (2013) · Cancer · doi:10.1002/cncr.27719 · Cited by 170
Acute liver failure induced by green tea extracts: Case report and review of the literature
Molinari, M., Watt, K. D. S., Kruszyna, T., Nelson, R., Walsh, M., Huang, W.-Y., Nashan, B., & Peltekian, K. (2006) · Liver Transplantation · doi:10.1002/lt.21021 · Cited by 170
Prognostic value of CRM1in pancreas cancer
Huang, W.-Y., Yue, L., Qiu, W.-S., Wang, L.-W., Zhou, X.-H., & Sun, Y.-J. (2009) · Clinical and Investigative Medicine · doi:10.25011/cim.v32i6.10668 · Cited by 170
CRM1-Mediated Nuclear Export of Proteins and Drug Resistance in Cancer
Turner, J., & Sullivan, D. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242859 · Cited by 169
Kazi, A., Daniel, K. G., Smith, D. M., Kumar, N. B., & Dou, Q. P. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00414-3 · Cited by 168
Self-citationHAMAMOTO, T., GUNJI, S., TSUJI, H., & BEPPU, T. (1983) · The Journal of Antibiotics · doi:10.7164/antibiotics.36.639 · Cited by 168
Li, G. (2010) · International Journal of Oncology · doi:10.3892/ijo_00000659 · Cited by 168
Quercetin: A Pleiotropic Kinase Inhibitor Against Cancer
Russo, G. L., Russo, M., Spagnuolo, C., Tedesco, I., Bilotto, S., Iannitti, R., & Palumbo, R. (2014) · Cancer Treatment and Research · doi:10.1007/978-3-642-38007-5_11 · Cited by 167
Self-citationThe Part and the Whole: functions of nucleoporins in nucleocytoplasmic transport
Wälde, S., & Kehlenbach, R. H. (2010) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.05.001 · Cited by 166
Kaminskyy, V. O., Piskunova, T., Zborovskaya, I. B., Tchevkina, E. M., & Zhivotovsky, B. (2012) · Autophagy · doi:10.4161/auto.20123 · Cited by 165
Hsp90 Inhibition Suppresses Mutant EGFR-T790M Signaling and Overcomes Kinase Inhibitor Resistance
Shimamura, T., Li, D., Ji, H., Haringsma, H. J., Liniker, E., Borgman, C. L., Lowell, A. M., Minami, Y., McNamara, K. L., Perera, S. A., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5428 · Cited by 164
Shimamura, T., Perera, S. A., Foley, K. P., Sang, J., Rodig, S. J., Inoue, T., Chen, L., Li, D., Carretero, J., Li, Y.-C., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2967 · Cited by 164
A quarter century of granzymes
Ewen, C. L., Kane, K. P., & Bleackley, R. C. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2011.153 · Cited by 162
Smit, L. A., Hallaert, D. Y. H., Spijker, R., de Goeij, B., Jaspers, A., Kater, A. P., van Oers, M. H. J., van Noesel, C. J. M., & Eldering, E. (2007) · Blood · doi:10.1182/blood-2006-05-021683 · Cited by 162
Beclin 2 Functions in Autophagy, Degradation of G Protein-Coupled Receptors, and Metabolism
He, C., Wei, Y., Sun, K., Li, B., Dong, X., Zou, Z., Liu, Y., Kinch, L. N., Khan, S., Sinha, S. C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.07.035 · Cited by 161
Gray‐Schopfer, V. C., Dias, S. D. R., & Marais, R. (2005) · Cancer and Metastasis Reviews · doi:10.1007/s10555-005-5865-1 · Cited by 160
Deng, J., Shimamura, T., Perera, S., Carlson, N. E., Cai, D., Shapiro, G. I., Wong, K.-K., & Letai, A. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1961 · Cited by 158
Autophagy as a target for cancer therapy: new developments
Nawrocki, S. T., Carew, & Kelly, K. (2012) · Cancer Management and Research · doi:10.2147/cmar.s26133 · Cited by 157
Bcl-2 Modulates Telomerase Activity
Mandal, M., & Kumar, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14183 · Cited by 156
Chronic lymphocytic leukemic cells exhibit apoptotic signaling via TRAIL-R1
MacFarlane, M., Inoue, S., Kohlhaas, S. L., Majid, A., Harper, N. W., Kennedy, D. B., Dyer, M. J. S., & Cohen, G. M. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401649 · Cited by 156
Phelps, M. A., Lin, T. S., Johnson, A. J., Hurh, E., Rozewski, D. M., Farley, K. L., Wu, D., Blum, K. A., Fischer, B., Mitchell, S. M., et al. (2008) · Blood · doi:10.1182/blood-2008-07-168583 · Cited by 156
Luo, T. L., Wang, J., Yin, Y., Hua, H., Jing, J., Sun, X., Li, M., Zhang, Y., & Jiang, Y. (2010) · Breast Cancer Research · doi:10.1186/bcr2473 · Cited by 152
Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin
Edmond, V., Moysan, E., Khochbin, S., Matthias, P., Brambilla, C., Brambilla, E. M., Gazzéri, S., & Eymin, B. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.333 · Cited by 151
Dietary polyphenols in cancer prevention: the example of the flavonoid quercetin in leukemia
Spagnuolo, C., Russo, M., Bilotto, S., Tedesco, I., Laratta, B., & Russo, G. L. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06599.x · Cited by 151
Self-citationPradelli, L. A., Bénéteau, M., Chauvin, C., Jacquin, M. A., Marchetti, S., Muñoz‐Pinedo, C., Auberger, P., Pende, M., & Ricci, J. (2009) · Oncogene · doi:10.1038/onc.2009.448 · Cited by 151
Liang, G., Tang, A., Lin, X., et al. (2010) · PubMed · Cited by 150
Androgens induce resistance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells.
Berchem, G., Bosseler, M., Sugars, L. V. Y., Voeller, H. J., Zeitlin, S., & Gelmann, E. P. (1995) · PubMed · Cited by 150
Balakrishnan, K., Burger, J. A., Wierda, W. G., & Gandhi, V. V. (2008) · Blood · doi:10.1182/blood-2008-02-138560 · Cited by 148
Constitutive activation of nuclear factor-κB prevents TRAIL-induced apoptosis in renal cancer cells
Oya, M., Ohtsubo, M., Takayanagi, A., Tachibana, M., Shimizu, N., & Murai, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204525 · Cited by 146
Cancer robustness: Tumour tactics
Kitano, H. (2003) · Nature · doi:10.1038/426125a · Cited by 146
Physiological cell death of chondrocytes in vivo is not confined to apoptosis
Roach, H. I., & Clarke, N. M. P. (2000) · Journal of Bone and Joint Surgery - British Volume · doi:10.1302/0301-620x.82b4.9846 · Cited by 145
Bortezomib as a Potential Treatment for Prostate Cancer
Papandreou, C. N., & Logothetis, C. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2707 · Cited by 144
Cited by
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Self-citationRegulated necrosis: disease relevance and therapeutic opportunities
Conrad, M., Angeli, J. P. F., Vandenabeele, P., & Stockwell, B. R. (2016) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2015.6 · Cited by 630
The multi-factorial nature of clinical multidrug resistance in cancer
Assaraf, Y. G., Brozovic, A., Gonçalves, A. C., Jurkovicova, D., Linē, A., Machuqueiro, M., Saponara, S., Sarmento-Ribeiro, A. B., Xavier, C. P. R., & Vasconcelos, M. H. (2019) · Drug Resistance Updates · doi:10.1016/j.drup.2019.100645 · Cited by 528
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
Efimova, I., Catanzaro, E., Van der Meeren, L., Turubanova, V. D., Hammad, H., Mishchenko, T. A., Vedunova, M. V., Fimognari, C., Bachert, C., Coppieters, F., et al. (2020) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001369 · Cited by 520
Self-citationOvercoming cancer therapeutic bottleneck by drug repurposing
Zhang, Z., Zhou, L., Xie, N., Nice, E. C., Zhang, T., Cui, Y., & Huang, C. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00213-8 · Cited by 516
Metadata
- Authors
- Mohammad, R. M., Muqbil, I., Lowe, L., Yedjou, C., Hsu, H.-Y., Lin, L.-T., Siegelin, M. D., Fimognari, C., Kumar, N. B., Dou, Q. P., Yang, H., Samadi, A. K., Russo, G. L., Spagnuolo, C., Ray, S. K., Chakrabarti, M., Morre, J. D., Coley, H. M., Honoki, K., Fujii, H., Georgakilas, A. G., Amedei, A., Niccolai, E., Amin, A., Ashraf, S. S., Helferich, W. G., Yang, X., Boosani, C. S., Guha, G., Bhakta, D., Ciriolo, M. R., Aquilano, K., Chen, S., Mohammed, S. I., Keith, W. N., Bilsland, A., Halicka, D., Nowsheen, S., & Azmi, A. S.
- Venue
- Seminars in Cancer Biology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 35
- Pages
- S78-S103
- ISSN
- 1044-579X (ISSN-L)
- OpenAlex
- W2072860434
- Cited by
- 864
- References
- 442
- FWCI
- 17.50
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.